Glaxo Smith Kline (EGX:BIOC) — Market Cap & Net Worth
Market Cap & Net Worth: Glaxo Smith Kline (BIOC)
Glaxo Smith Kline (EGX:BIOC) has a market capitalization of $120.19 (EGP6.38K) as of April 18, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #41535 globally and #47 in its home market, demonstrating a 4.59% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Glaxo Smith Kline's stock price EGP63.81 by its total outstanding shares 100 (100.00).
Glaxo Smith Kline Market Cap History: 2015 to 2026
Glaxo Smith Kline's market capitalization history from 2015 to 2026. Data shows growth from $14.66 to $120.19 (22.23% CAGR).
Glaxo Smith Kline Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Glaxo Smith Kline's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BIOC by Market Capitalization
Companies near Glaxo Smith Kline in the global market cap rankings as of April 18, 2026.
Key companies related to Glaxo Smith Kline by market ranking:
- 206950 (KO:206950): Ranked #41526 globally with a market cap of $121.64 USD ( ₩179.50K KRW).
- MPACT -NPV- (BE:M8P): Ranked #41527 globally with a market cap of $121.59 USD ( €104.00 EUR).
- Ssangyong Materials Corp. (KQ:047400): Ranked #41536 globally with a market cap of $120.15 USD ( ₩177.30K KRW).
- DYC Co. Ltd. (KO:310870): Ranked #41537 globally with a market cap of $120.15 USD ( ₩177.30K KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #41526 | 206950 | KO:206950 | $121.64 | ₩1795.00 |
| #41527 | MPACT -NPV- | BE:M8P | $121.59 | €1.04 |
| #41536 | Ssangyong Materials Corp. | KQ:047400 | $120.15 | ₩1773.00 |
| #41537 | DYC Co. Ltd. | KO:310870 | $120.15 | ₩1773.00 |
Glaxo Smith Kline Historical Marketcap From 2015 to 2026
Between 2015 and today, Glaxo Smith Kline's market cap moved from $14.66 to $ 120.19, with a yearly change of 22.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP120.19 | +0.25% |
| 2025 | EGP119.88 | +76.81% |
| 2024 | EGP67.81 | +1.27% |
| 2023 | EGP66.96 | -6.84% |
| 2022 | EGP71.87 | +23.58% |
| 2021 | EGP58.16 | +82.08% |
| 2020 | EGP31.94 | -14.17% |
| 2019 | EGP37.22 | 0.00% |
| 2018 | EGP37.22 | +45.48% |
| 2017 | EGP25.58 | +87.35% |
| 2016 | EGP13.65 | -6.87% |
| 2015 | EGP14.66 | -- |
End of Day Market Cap According to Different Sources
On Apr 17th, 2026 the market cap of Glaxo Smith Kline was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $120.19 USD |
| MoneyControl | $120.19 USD |
| MarketWatch | $120.19 USD |
| marketcap.company | $120.19 USD |
| Reuters | $120.19 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Glaxo Smith Kline
Glaxo Smith Kline operates in various business sectors.